Intuitive Surgical Stock Drops 30% Despite Earnings Beat and Margin Expansion

Key Facts

At a time when the med-tech sector is facing increased scrutiny over procedure growth rates, Intuitive Surgical is experiencing significant price volatility. The stock has declined nearly 30% from its recent peak, despite reporting strong second-quarter financial results where earnings per share beat estimates by $0.30. According to reports, the company demonstrated high operational efficiency as non-GAAP gross margins expanded to 70%, while operating margins reached 42.1%.

This decline comes amid investor concerns regarding softer growth in U.S. surgical procedures, which overshadowed the resilient adoption metrics of the Da Vinci surgical systems. In comparison to peers, Stryker reported 9% organic sales growth in its latest quarter per its earnings data, indicating a competitive environment in the medical device space. Per market data, the current selling pressure reflects a re-rating of the high valuation multiples the stock previously held relative to its sector counterparts.

As of the close on July 16, 2026, ISRG stood at $402.33, having touched a daily low of $393.68. Traders are currently monitoring support levels near the $400 mark to determine the stock's next direction. Looking at the economic calendar, while there are no immediate medical-sector catalysts, upcoming speeches from Fed officials may influence broader market sentiment toward high-growth and technology-driven stocks.